Definitive Contract 75D30120C08533
Award Date 6/15/20
Potential Completion Date 6/14/21
Potential Value $23M
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Marshfield, WI, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $10.8 million definitive cost-no-fee contract to Marshfield Clinic to conduct a prospective cohort study to assess transmission patterns, rates of infection, illness characteristics, and medically and non-medically attended cases of COVID-19 and other respiratory viruses. Marshfield Clinic will recruit and follow individuals of all ages for up to 12 months in Marshfield, Wisconsin. The...
- Marshfield Clinic, Inc. was awarded a $1,725,838 firm fixed price definitive contract from the Centers for Disease Control and Prevention (CDC) to support Topic 9 under the Fiscal Year 2021 Broad Agency Announcement. As the prime contractor, Marshfield Clinic will provide services related to the specified topic in Marshfield, Wisconsin through September 30, 2022. No set-aside designation was applied to this contract. Marshfield Clinic is a non-profit health care organization that conducts...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, to enhance the serum repository for Lyme disease. The contract has a ceiling value of $237,421.00 and a completion date of September 24, 2022. Marshfield Clinic has a long history of partnering with the CDC and other federal agencies on public health initiatives, including vaccine safety monitoring and COVID-19 research. This...
- Marshfield Clinic, Inc. was awarded a $200,030 firm fixed price purchase order by the Centers for Disease Control and Prevention to conduct a follow-up measles, mumps, and rubella vaccine response study. The award was made without a set-aside designation under a June 2020 solicitation seeking a contractor to perform targeted DNA sequencing of samples from participants in the Centers for Disease Control and Prevention's MMR3 Long-Term Follow-Up Study. Marshfield Clinic will sequence genomic...
- This federal contract award to Marshfield Clinic, Inc., a non-profit healthcare organization, is for the SERUM REPOSITORY project. The contract, awarded by the Centers for Disease Control and Prevention (CDC), has a ceiling value of $1,230,268.00 and is a Definitive Contract with a Firm Fixed Price pricing type. The ultimate completion date is September 24, 2028. This contract is not a set-aside award. Marshfield Clinic, Inc. is the prime contractor, and its parent organization is Marshfield...
- Marshfield Clinic, Inc. has been awarded a definitive cost-no-fee contract from the Department of Health and Human Services Centers for Disease Control and Prevention valued at up to $424,312. The contract calls for an epidemiologic assessment of Lyme disease diagnoses in electronic health records to support the agency's objectives. As the prime contractor, Marshfield Clinic will analyze Lyme disease data extracted from electronic health records to provide epidemiologic insights. The contract...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, for a project titled "USING ELECTRONIC HEALTH RECORDS TO IDENTIFY AND DESCRIBE". The contract has a ceiling value of $1,029,344.00 and a period of performance ending on September 27, 2027. It is a firm fixed price contract and was not set aside for any particular business type. Marshfield Clinic, Inc. is a subsidiary of...
- This is a federal contract award issued by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization in Marshfield, Wisconsin. The $241,487 firm fixed-price contract is for "ENHANCING THE SERUM REPOSITORY FOR LYME DISEASE" and has a period of performance through December 31, 2023. Marshfield Clinic, Inc. is a subsidiary of the parent organization Marshfield Clinic Health System, Inc., which has a significant history of federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $106,950 firm-fixed-price purchase order to Marshfield Clinic, Inc., a non-profit healthcare organization, to use electronic health records to identify and describe Lyme disease diagnoses. This contract, which does not have a set-aside designation, was awarded on September 14, 2020 with a completion date of September 30, 2021. Marshfield Clinic is a prime contractor that provides the CDC with...
- This $1,989,636.00 cost-plus-fixed-fee contract was awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, to conduct a study on the measles, mumps, and rubella vaccine (MMR3 STUDY). The contract has an ultimate completion date of May 9, 2012. Marshfield Clinic, Inc. is a long-standing partner with the CDC, having supported various public health initiatives and vaccine safety monitoring efforts through federal contracts...
Marshfield Clinic has been awarded a definitive cost-no-fee contract valued at $22.6 million by the Centers for Disease Control and Prevention to provide centralized molecular assessment of SARS and influenza virus infections for multi-site prospective cohorts. The contract will support the CDC's efforts to respond to the Coronavirus COVID-19 pandemic through prospective cohort studies and molecular testing of samples from infected individuals. Marshfield Clinic will serve as the prime contractor and perform all work in Marshfield, Wisconsin. The contract period of performance spans just over one year, from June 2020 through June 2021.
Generated 12/25/23, 3:05 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.6m | 6/29/20 |